See what questions
a doctor would ask.
Prudential Financial states that Novartis will probably be disappointed in the upcoming VALUE study results which compares Novartis' hypertension drug (Diovan) with Pfizer's Norvasc. The study will compare effectiveness in reducing cardiovascular events in patients with hypertension.
Source: summary of medical news story as reported by Prudential Financial
About: Study compares Novartis hypertension drug to Pfizer's
Date: 10 June 2004
Source: Prudential Financial
More News Topics
Search Specialists by State and City